Great rankings for Bryn Aarflot in the MIP Global Survey for 2018
As the first set of results of the research for the 2018 edition of IP STARS is presented, we are proud to announce that Bryn Aarflot has been ranked in the top tier for trademark prosecution and tier 2 for trademark contentious work in Norway.Read more
Bryn Aarflot receives top ranking in WTR 1000 for 2018
Bryn Aarflot’s trademark practice has once again been ranked among Norway’s leading law firms for trademarks in the 2018 edition of World Trademark Review 1000 – The World’s Leading Trademark Professionals.Read more
Bryn Aarflot attending INTA 2018
Bryn Aarflot is heading to Seattle for the INTA Annual Meeting in May!Read more
WTR Trademark Litigation Guide Norway
Everything you always wanted to know about trademark litigation in Norway (but were afraid to ask).Read more
Bryn Aarflot successfully helped Intervet International in winning appeal
Bryn Aarflot has successfully helped Intervet International BV in winning appeal proceedings between Intervet (Defendant) and Pharmaq AS (Appellant).
Pharmaq decided to appeal the Norwegian Industrial Property Office’s (NIPO) decision to revoke Norwegian patent No. 333242 after opposition proceedings initiated by Intervet represented by Bryn Aarflot.
The patent concerned a vaccine against pancreas disease in fish. Intervet argued that the patent claims were not novel in view of an oral presentation. NIPO had in their patentability assessment during the opposition proceedings decided that it was unclear whether there was sufficient evidence proving that the presentation was presented and publically available prior to the date of filing.
The Board of Appeal concluded that the evidence was sufficient. They rejected the appeal and the patent remains revoked.Read more